DUSP5
Dual specificity protein phosphatase 5
Also known as: DUS5_HUMAN, HVH3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16690
- Gene
- DUSP5
- Ensembl
- ENSG00000138166
- Chromosome
- 10
- Canonical length
- 384 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1, is expressed in a variety of tissues with the highest levels in pancreas and brain, and is localized in the nucleus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
384 residues, UniProt reviewed canonical sequence.
>Q16690|DUSP5
1 MKVTSLDGRQ LRKMLRKEAA ARCVVLDCRP YLAFAASNVR GSLNVNLNSV VLRRARGGAV
61 SARYVLPDEA ARARLLQEGG GGVAAVVVLD QGSRHWQKLR EESAARVVLT SLLACLPAGP
121 RVYFLKGGYE TFYSEYPECC VDVKPISQEK IESERALISQ CGKPVVNVSY RPAYDQGGPV
181 EILPFLYLGS AYHASKCEFL ANLHITALLN VSRRTSEACA THLHYKWIPV EDSHTADISS
241 HFQEAIDFID CVREKGGKVL VHCEAGISRS PTICMAYLMK TKQFRLKEAF DYIKQRRSMV
301 SPNFGFMGQL LQYESEILPS TPNPQPPSCQ GEAAGSSLIG HLQTLSPDMQ GAYCTFPASV
361 LAPVPTHSTV SELSRSPVAT ATSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 164 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 164 nTPM
- esophagus: 115 nTPM
- choroid plexus: 74 nTPM
- gallbladder: 48 nTPM
- placenta: 45 nTPM
- adrenal gland: 42 nTPM
Single-cell type
- esophageal apical cells: 653 nCPM
- ocular epithelial cells: 569 nCPM
- urothelial cells: 550 nCPM
- plasma cells: 431 nCPM
- pdcs: 404 nCPM
- endometrial glandular cells: 330 nCPM
Immune cell
- plasmacytoid DC: 15 nTPM
- non-classical monocyte: 10 nTPM
- gdT-cell: 3.5 nTPM
- intermediate monocyte: 2.2 nTPM
- memory CD4 T-cell: 1.8 nTPM
- MAIT T-cell: 1.3 nTPM
Brain region
- cerebellum: 44 nTPM
- hippocampal formation: 28 nTPM
- cerebral cortex: 24 nTPM
- choroid plexus: 17 nTPM
- hypothalamus: 16 nTPM
- thalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DUSP5.
Disease | ImmuneIEDB
Conditions an epitope on DUSP5 was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.69
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dephosphorylation
- endoderm formation
- ERK1 and ERK2 cascade
- MAPK cascade
- negative regulation of MAPK cascade
- peptidyl-threonine dephosphorylation
- peptidyl-tyrosine dephosphorylation
- protein dephosphorylation
- signal transduction
Molecular functions
- MAP kinase tyrosine/serine/threonine phosphatase activity
- phosphatase activity
- phosphoprotein phosphatase activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Rhodanese-like domain
- Protein-tyrosine phosphatase, catalytic
- Mitogen-activated protein (MAP) kinase phosphatase
- Protein-tyrosine phosphatase, active site
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Rhodanese-like domain superfamily
- Rhodanese-like domain
- Dual specificity phosphatase, catalytic domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP5 as an antibody target. Whether an autoantibody or antibody against DUSP5 could matter depends on whether native DUSP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...